Harbour BioMed & Evinova Team Up, Cornerstone Robotics Secures $200M - Life AI Weekly #42
November 12, 2025 -
Life AI Weekly
Hi there,
In this edition of Life AI Weekly, we delve into the latest advancements in healthcare and life sciences AI. Harbour BioMed and Evinova have teamed up to enhance biologics development using AI, aiming to streamline the drug discovery process. Meanwhile, the Critical Path Institute has launched an AI coalition focused on pediatric IBD drug development, highlighting the growing role of AI in addressing complex medical challenges.
On the business front, Cornerstone Robotics has secured $200 million to expand its operations, emphasizing the increasing investment in AI-driven healthcare solutions. Additionally, Tala Health has raised $100 million to further integrate AI into healthcare, showcasing the sector's commitment to innovation. Stay tuned as we explore these stories and more, shedding light on how AI continues to transform the healthcare landscape.
In this edition of Life AI Weekly, we delve into the latest advancements in healthcare and life sciences AI. Harbour BioMed and Evinova have teamed up to enhance biologics development using AI, aiming to streamline the drug discovery process. Meanwhile, the Critical Path Institute has launched an AI coalition focused on pediatric IBD drug development, highlighting the growing role of AI in addressing complex medical challenges.
On the business front, Cornerstone Robotics has secured $200 million to expand its operations, emphasizing the increasing investment in AI-driven healthcare solutions. Additionally, Tala Health has raised $100 million to further integrate AI into healthcare, showcasing the sector's commitment to innovation. Stay tuned as we explore these stories and more, shedding light on how AI continues to transform the healthcare landscape.
Business, Investments & Partnerships
Cornerstone Robotics has secured $200 million to expand its robotic surgical systems for minimally invasive procedures in hospitals across mainland China. Meanwhile, Expanse Medical is expanding to Providence, Rhode Island, with a new facility focused on AI-driven men's health innovations through Valorian Medical Technologies.
- Cornerstone Robotics Secures $200 Million for Expansion
- IISc Foundation and IndusSetu Partner for AI in Healthcare
- Scientist.com CTO Chris Petersen Wins 2025 CTO of the Year
- Tala Health Secures $100 Million for AI Healthcare
- Novo Holdings Invests €188 Million in Quantum Tech
- PureHealth Reports Revenue and Expands with Acquisition
- Supreme Group Appoints New Executive VP for Healthcare Growth
- SOPHiA GENETICS and Element Biosciences Partner for AI in Precision Medicine
- Silicon Valley Bank Reports Record AI Investment in Healthtech
- ABK Biomedical Raises $35 Million for AI Medical Devices
- Expanse Medical Expands to Rhode Island with AI Men's Health Innovations
Drug Discovery
Harbour BioMed and Evinova have partnered to enhance biologics development using AI and digital technologies, aiming to improve drug development efficiency and foster an open R&D ecosystem. Meanwhile, the Critical Path Institute has launched the Critical Path Disease Modeling Coalition in Amsterdam to develop models for pediatric inflammatory bowel disease, targeting conditions like Crohn's disease and ulcerative colitis.
- Harbour BioMed and Evinova Partner on AI in Biologics
- Critical Path Institute Launches AI Coalition for Pediatric IBD Drug Development
- GT Biopharma Progresses in Oncology with Clinical Trials
Biotech
Anthill launched Anthill Cloud™, an AI platform for Pharma marketing, on November 3, 2025. EXoPERT joined JLABS TMC in Johnson & Johnson's incubator to advance AI-powered cancer diagnostics. The RNA Horizons 2025 Symposium in Palermo highlighted advances in RNA therapeutics and AI applications.
- Anthill Unveils AI Platform for Pharma Marketing
- EXoPERT Joins JLABS TMC in Johnson & Johnson's Incubator
- RNA Horizons 2025 Symposium Highlights RNA and AI Advances
Healthcare Tech
ACTO launched the ACTOverse Marketplace at the Veeva Commercial Summit in Europe, offering a digital platform to integrate content, data, and service solutions for biopharmaceutical and medical device companies. Meanwhile, Akkodis unveiled AI-driven solutions across various industries, including life sciences and IT operations, showcasing projects that enhance efficiency and workforce transformation.
- ACTO Launches ACTOverse at Veeva Summit
- Akkodis Unveils AI Innovations Across Industries
- National Health Council Launches PXI Center
- Conexiant Introduces AI Platform MDspire for Healthcare
- Diversis Capital Merges Companies for AI Healthcare Platform
- AI CoLab Hosts 'AI for Health' Summit with MedStar and Georgetown
- CereCore Joins Oracle Partner Program for AI Healthcare Solutions
- Future of Health Summit Presents AI-Driven Healthcare Roadmap
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
11/12
Diversis Capital Merges Genesis Automation Healthcare, Kermit, and Meperia
11/12
AI CoLab Hosts Second Annual 'AI for Health' Summit in Washington
11/12
SOPHiA GENETICS and Element Biosciences Integrate AI and Sequencing Platforms for Precision Medicine Research
11/12
Global Health Leaders Outline AI-Driven Roadmap at Future of Health Summit
11/12
CereCore Joins Oracle Partner Program to Expand Healthcare IT Services